Gut microbiome and rheumatoid arthritis: Revisiting the gut-joint axis
International Immunopharmacology · 2025-11 · 165 · 115503
DOI: 10.1016/j.intimp.2025.115503 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025-11. Verfasst von Bhupinder Kapoor und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India. Electronic address: Bhupipharma@gmail.com. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Arthritis, Rheumatoid, Dysbiosis, Joints. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 183 Literaturangaben.
Abstract (Originalsprache)
Over the past few decades, the scientific perspective on gut microbiota has undergone a profound transformation, particularly with the emergence and advancement of microbiome research. Next-generation sequencing technologies have emerged as a foundational tool in microbiome research, facilitating comprehensive characterization of microbial communities across diverse sample types and ecological niches. Significant alterations in gut microbiota composition have been observed in disease states compared to healthy individuals, suggesting a direct association between gut dysbiosis and host health status. Initially, alterations in gut microbiota were primarily thought to be associated with gastrointestinal disorders. With advancing research, however, it has become evident that gut dysbiosis is also implicated in a broad spectrum of extra-intestinal conditions, including neurological, dermatological, metabolic, and musculoskeletal diseases. The present review provides a comprehensive analysis of preclinical and clinical studies elucidating the role of gut dysbiosis in the pathogenesis and progression of rheumatoid arthritis. Advancements in the understanding of the gut-joint axis have facilitated the development of novel therapeutic modalities, including probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, that have been comprehensively discussed in present review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India. Electronic address: Bhupipharma@gmail.com.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Zitieren
APA
Kapoor, B., & Gulati, M. (2025). Gut microbiome and rheumatoid arthritis: Revisiting the gut-joint axis. International Immunopharmacology, 165, 115503. https://doi.org/10.1016/j.intimp.2025.115503
Vancouver
Kapoor B, Gulati M. Gut microbiome and rheumatoid arthritis: Revisiting the gut-joint axis. International Immunopharmacology. 2025;165:115503. doi:10.1016/j.intimp.2025.115503
BibTeX
@article{Kapoor2025,
author = {Kapoor, Bhupinder and Gulati, Monica},
title = {Gut microbiome and rheumatoid arthritis: Revisiting the gut-joint axis},
journal = {International Immunopharmacology},
year = {2025},
volume = {165},
pages = {115503},
doi = {10.1016/j.intimp.2025.115503}
}
EUVIMED